Glycoaish N 0.5mg/2.5mg Injection
Marketer
Aishwarya Healthcare
Salt Composition
Glycopyrrolate (0.5mg) + Neostigmine (2.5mg)
Overview Glycoaish N 0.5mg/2.5mg Injection
NeoGlyc 0.5mg/2.5mg injection is a dual-action medication administered during surgical anesthesia. Administration is by a physician or registered nurse, with dosage tailored to individual patient needs and response. Inform your medical team of all other medications you're using, as interactions are possible. The most frequently reported adverse effect is an allergic reaction; typically transient and self-limiting. However, report any concerns to your doctor immediately. Drowsiness and vertigo are also possible; avoid driving or activities demanding concentration until the effects are known. Alcohol consumption should be avoided due to potential exacerbation of dizziness. Prior to treatment, disclose any pregnancy, pregnancy plans, breastfeeding, or pre-existing kidney, liver, or gastric conditions to enable appropriate dosage selection.
Uses of Glycoaish N 0.5mg/2.5mg Injection
Counteracting the pharmacological impact of specific surgical medications.
Major Benefits of Glycoaish N 0.5mg/2.5mg Injection:
The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Glycoaish N 0.5mg/2.5mg Injection:
- Allergic reaction
How to use Glycoaish N 0.5mg/2.5mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Glycoaish N 0.5mg/2.5mg Injection works:
Glycoaish N Injection, containing 0.5mg glycopyrrolate and 2.5mg neostigmine, is a dual-drug formulation.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Glycoaish N 0.5mg/2.5mg Injection and alcohol can lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
The use of Glycoaish N 0.5mg/2.5mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Patient consultation with their doctor is advised.
Breast feedingSAFE IF PRESCRIBED
Glycoaish N 0.5mg/2.5mg Injection appears compatible with breastfeeding. Available human data indicates minimal infant risk. However, prolonged Glycoaish N 0.5mg/2.5mg Injection use may decrease lactation.
DrivingUNSAFE
Glycoaish N 0.5mg/2.5mg Injection can induce adverse reactions that might impair driving. Impaired vision and coordination, potential consequences of Glycoaish N 0.5mg/2.5mg Injection, could compromise driving safety.
KidneyCAUTION
Individuals with impaired kidney function should exercise caution when using Glycoaish N 0.5mg/2.5mg Injection. Dosage modification of Glycoaish N 0.5mg/2.5mg Injection might be necessary. Physician consultation is recommended. Routine monitoring of renal function and certain blood parameters may be advisable during treatment.
LiverSAFE IF PRESCRIBED
Glycoaish N 0.5mg/2.5mg Injection appears to pose minimal risk for individuals with hepatic impairment. Existing evidence indicates dose modification may be unnecessary; however, medical advice is recommended.
What if you forget to take Glycoaish N 0.5mg/2.5mg Injection :
Should you inadvertently omit a scheduled dose of Glycoaish N 0.5mg/2.5mg Injection, seek immediate medical advice.
Facts to Know About Glycoaish N 0.5mg/2.5mg Injection
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Medication Classification | Nervous system medications |
3,018 People bought this recently